Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

• Autores: Mingzhao Xing, Ali S. Alzahrani, Kathryn A. Carson, David Viola, Pilar Santisteban
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 309, Nº. 14, 2013, págs. 1493-1501
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its role in PTC-related patient mortality has not been established.